Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir/sofosbuvir. [electronic resource]
Producer: 20190916Description: 1409-1415 p. digitalISSN:- 1365-2036
- Abdominal Pain -- epidemiology
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Benzimidazoles -- administration & dosage
- Drug Therapy, Combination
- Esophageal and Gastric Varices -- epidemiology
- Fatigue -- chemically induced
- Female
- Fluorenes -- administration & dosage
- Gastrointestinal Hemorrhage -- epidemiology
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Liver Cirrhosis -- drug therapy
- Liver Transplantation
- Male
- Middle Aged
- Nausea -- chemically induced
- Prospective Studies
- Ribavirin -- administration & dosage
- Simeprevir -- administration & dosage
- Sofosbuvir
- Sustained Virologic Response
- Uridine Monophosphate -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.